Neurocrine Biosciences develops and sells medicines for neurological, psychiatric and endocrine disorders, based in San Diego. It last closed at $150.57 on Nov 20, down 3.84% on the day. The next earnings report for NBIX is expected around Wed, Feb 10, 2027, after the close. For the quarter ended Sep 2026, NBIX reported EPS of $1.96 on revenue of $1.12B, with revenue up 41.2% from a year ago. Over its last 8 reports the stock moved an average of 10.3% the session after earnings. Over the last 12 months NBIX insiders bought $0 of stock on the open market and sold $79.9M, according to SEC Form 4 filings.
AI Auto Pilots
Is NBIX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NBIX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on NBIXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
NBIX · as of the Nov 20 close · updated each morning
Moving sideways
The stock sits between its 20 and 50 day averages. It is sitting right on its 200 day average, a level many traders watch. Momentum is weak (RSI 43). The nearest support is the 200 day average at $149.44, and the nearest resistance the Pivot at $153.02.
Short trendNeutral
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityHigh, 3.7%/day
Key levels
$186.1252 week high+23.6%
$159.0520 day average+5.6%
$156.93100 day average+4.2%
$156.56Swing high (Aug 19)+4.0%
$155.80Pivot R1+3.5%
$153.02Pivot+1.6%
$150.57Last close
$149.44200 day average−0.8%
$149.0350 day average−1.0%
$148.78Swing low (Aug 14)−1.2%
$147.79Pivot S1−1.8%
$122.1452 week low−18.9%
Indicators
RSI (14)
42.95
Middle of its range
Neutral
MACD
3.59
Below its signal line
Bearish
Stochastic
35.0
Middle of its range
Neutral
ADX (14)
29.5
Trending down
Williams %R
-98.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-46.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−8.5%
Change over 10 sessions
Bearish
ATR (14)
$5.63
Typical daily range, 3.7% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendBullish
MomentumImproving
StretchNormal
VolatilityHigh, 7.6%/day
Key levels
$186.1252 week high+23.6%
$159.0520 day average+5.6%
$156.93100 day average+4.2%
$156.56Swing high (Aug 19)+4.0%
$155.80Pivot R1+3.5%
$153.02Pivot+1.6%
$150.57Last close
$149.44200 day average−0.8%
$149.0350 day average−1.0%
$148.78Swing low (Aug 14)−1.2%
$147.79Pivot S1−1.8%
$122.1452 week low−18.9%
Indicators
RSI (14)
49.32
Middle of its range
Neutral
MACD
0.54
Above its signal line
Bullish
Stochastic
70.0
Middle of its range
Neutral
ADX (14)
21.0
Weak trend
Williams %R
-56.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
3.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−3.6%
Change over 10 sessions
Bearish
ATR (14)
$11.38
Typical daily range, 7.6% of price
MA 10Above
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for NBIX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how NBIX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow NBIX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for NBIXHow many large options trades hit NBIX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in NBIX in the last 90 days.
From SEC Form 4 filings by NBIX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NBIX is in one of them and how their past NBIX trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Neurocrine Biosciences
Neurocrine Biosciences is a biopharmaceutical company based in San Diego, California. It discovers, develops and sells medicines for neurological, psychiatric, endocrine and immune disorders. Its main product, INGREZZA, treats tardive dyskinesia and chorea linked to Huntington's disease, and CRENESSITY treats congenital adrenal hyperplasia. In the United States, it sells through specialty pharmacies and distributors, and its sales teams focus on neurology, psychiatry, long-term care and rare diseases.